BEIJING (Reuters) - China’s drug safety watchdog has suspended sales of a drug used to treat acute leukemia and rheumatoid arthritis, Xinhua news agency said on Saturday, the latest in a string of food and drug security scandals.China has faced sharp international criticism, especially from the United States, for failing to stop exports of toxic medical ingredients, foods and toys, and China’s own national leadership has demanded stricter food and medicine standards.
